The Immunotherapy and COVID risk is prevalent. Throughout the outbreak, the immunotherapy community was uniquely challenged by circumstances.
Immunotherapy and COVID risk
Immunotherapy and COVID risk
Practically every aspect of modern life now is up and down by the ongoing COVID-19 pandemic. Substantial disruptions to the day-to-day practices of caring for patients in merely a year time period…